Healthcare -
Biotechnology - NYSE - US
$ 8.475
2.85 %
$ 487 M
Market Cap
-0.8
P/E
DNA - GROSS PROFIT
Gross Profit DNA - Ginkgo Bioworks Holdings, Inc.
197 M
LAST VALUE
3.55%
2 YEAR CAGR
14.97%
5 YEAR CAGR
0.00%
10 YEAR CAGR